GLENN F TILTON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GLENN F TILTON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GLENN F TILTON. GLENN F TILTON is in ABBOTT LABORATORIES ($ABT) and Director in ABBOTT LABORATORIES ($ABT) and Chairman & CEO in United Continental Holdings, Inc. ($UAL) and Chairman, President & CEO in United Continental Holdings, Inc. ($UAL) and Chairman,President & CEO in United Continental Holdings, Inc. ($UAL) and Director in Phillips 66 ($PSX) and Director in AbbVie Inc. ($ABBV).
Latest Insider Trading Transactions of GLENN F TILTON
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABT, ABBV, PSX, UAL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11 2021 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 1,681 | 0 | 46,168 | 44.5 K to 46.2 K (+3.78 %) |
| Apr 27 2021 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Grant | A | 0.00 | 1,499 | 0 | 44,526 | 43 K to 44.5 K (+3.48 %) | |
| Jan 20 2021 | PSX | Phillips 66 | TILTON GLENN F | Director | Grant | A | 72.19 | 2,771 | 200,045 | 36,303 | 33.5 K to 36.3 K (+8.26 %) |
| May 12 2020 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 2,333 | 0 | 44,487 | 42.2 K to 44.5 K (+5.53 %) |
| Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Grant | A | 0.00 | 1,974 | 0 | 43,027 | 41.1 K to 43 K (+4.81 %) |
| Jan 17 2020 | PSX | Phillips 66 | TILTON GLENN F | Director | Grant | A | 104.92 | 1,907 | 200,073 | 32,103 | 30.2 K to 32.1 K (+6.32 %) |
| May 07 2019 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 2,419 | 0 | 42,154 | 39.7 K to 42.2 K (+6.09 %) |
| Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Grant | A | 0.00 | 2,241 | 0 | 41,053 | 38.8 K to 41.1 K (+5.77 %) |
| Jan 17 2019 | PSX | Phillips 66 | TILTON GLENN F | Director | Grant | A | 92.84 | 2,155 | 200,059 | 29,335 | 27.2 K to 29.3 K (+7.93 %) |
| Jun 29 2018 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Buy | P | 91.90 | 5,400 | 496,274 | 39,735 | 34.3 K to 39.7 K (+15.73 %) |
| May 07 2018 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 1,899 | 0 | 34,335 | 32.4 K to 34.3 K (+5.85 %) |
| May 07 2018 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 1,899 | 0 | 34,335 | 32.4 K to 34.3 K (+5.85 %) |
| May 01 2018 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Grant | A | 0.00 | 2,945 | 0 | 38,812 | 35.9 K to 38.8 K (+8.21 %) |
| Jan 18 2018 | PSX | Phillips 66 | TILTON GLENN F | Director | Grant | A | 104.03 | 1,923 | 200,050 | 20,657 | 18.7 K to 20.7 K (+10.26 %) |
| Jan 03 2018 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 578 | 0 | 31,629 | |
| Jan 03 2018 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 387 | 0 | 29,229 | |
| Jul 05 2017 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 678 | 0 | 30,120 | |
| Jul 05 2017 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 517 | 0 | 27,970 | |
| May 09 2017 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 2,770 | 0 | 32,436 | 29.7 K to 32.4 K (+9.34 %) |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Grant | A | 0.00 | 3,437 | 0 | 35,867 | 32.4 K to 35.9 K (+10.60 %) |
| Apr 04 2017 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 575 | 0 | 27,191 | |
| Apr 04 2017 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 743 | 0 | 29,265 | |
| Jan 18 2017 | PSX | Phillips 66 | TILTON GLENN F | Director | Grant | A | 83.61 | 2,392 | 200,001 | 18,134 | 15.7 K to 18.1 K (+15.20 %) |
| Jan 04 2017 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 598 | 0 | 26,342 | |
| Jan 04 2017 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 859 | 0 | 28,351 | |
| Oct 04 2016 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 594 | 0 | 25,512 | |
| Oct 04 2016 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 780 | 0 | 27,313 | |
| Jul 15 2016 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 573 | 0 | 24,709 | |
| Jul 05 2016 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 839 | 0 | 26,381 | |
| May 10 2016 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 2,974 | 0 | 29,666 | 26.7 K to 29.7 K (+11.14 %) |
| May 03 2016 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Grant | A | 0.00 | 3,799 | 0 | 32,430 | 28.6 K to 32.4 K (+13.27 %) |
| Apr 04 2016 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 603 | 0 | 23,917 | |
| Apr 01 2016 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 788 | 0 | 25,369 | |
| Jan 19 2016 | PSX | Phillips 66 | TILTON GLENN F | Director | Grant | A | 77.61 | 2,578 | 200,066 | 15,276 | 12.7 K to 15.3 K (+20.30 %) |
| Jan 05 2016 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 582 | 0 | 23,067 | |
| Jan 05 2016 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 734 | 0 | 24,413 | |
| Oct 02 2015 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 820 | 0 | 23,550 | |
| Oct 02 2015 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 634 | 0 | 22,295 | |
| Jul 02 2015 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 672 | 0 | 22,621 | |
| Jul 02 2015 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 513 | 0 | 21,501 | |
| May 12 2015 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 2,187 | 0 | 26,692 | 24.5 K to 26.7 K (+8.92 %) |
| Apr 28 2015 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Grant | A | 0.00 | 2,793 | 0 | 28,631 | 25.8 K to 28.6 K (+10.81 %) |
| Apr 02 2015 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 589 | 0 | 20,827 | |
| Apr 02 2015 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 712 | 0 | 21,841 | |
| Apr 28 2009 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Grant | A | 0.00 | 2,465 | 0 | 13,112 | 10.6 K to 13.1 K (+23.15 %) |
| Apr 02 2009 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 534 | 0 | 3,723 | |
| Feb 27 2009 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Buy | P | 53.63 | 2,000 | 107,260 | 10,647 | 8.6 K to 10.6 K (+23.13 %) |
| Jan 05 2009 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 477 | 0 | 3,167 | |
| Oct 02 2008 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 442 | 0 | 2,672 | |
| Jul 02 2008 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 481 | 0 | 2,216 | |
| Apr 29 2008 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Grant | A | 0.00 | 1,917 | 0 | 8,647 | 6.7 K to 8.6 K (+28.48 %) |
| Apr 02 2008 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 462 | 0 | 1,723 | |
| Jan 02 2008 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 454 | 0 | 1,253 | |
| Oct 02 2007 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 475 | 0 | 795 | |
| Sep 19 2007 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Buy | P | 52.49 | 4,390 | 230,420 | 4,390 | 0 to 4.4 K |
| Jul 03 2007 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 317 | 0 | 317 | |
| May 01 2007 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Grant | A | 0.00 | 1,730 | 0 | 2,340 | 610 to 2.3 K (+283.61 %) |
| Mar 06 2006 | UAL | United Continental ... | TILTON GLENN F | Chairman & CEO | Option Exercise | A | 35.65 | 274,000 | 9,768,100 | 274,000 | |
| Feb 24 2006 | UAL | United Continental ... | TILTON GLENN F | Chairman & CEO | Option Exercise | A | 35.91 | 274,000 | 9,839,340 | 274,000 | |
| Feb 17 2006 | UAL | United Continental ... | TILTON GLENN F | Chairman & CEO | Option Exercise | A | 34.18 | 274,000 | 9,365,320 | 274,000 | |
| May 24 2004 | UAL | United Continental ... | TILTON GLENN F | Chairman, President ... | Gift | G | 0.00 | 45,413 | 0 | 0 | 45.4 K to 0 (-100.00 %) |
| May 13 2004 | UAL | United Continental ... | TILTON GLENN F | Chairman, President ... | Payment of Exercise | F | 1.07 | 29,587 | 31,658 | 45,413 | 75 K to 45.4 K (-39.45 %) |
| Nov 14 2003 | UAL | United Continental ... | TILTON GLENN F | Chairman, President ... | Gift | G | 0.00 | 15,138 | 0 | 75,000 | 90.1 K to 75 K (-16.79 %) |
| Sep 04 2003 | UAL | United Continental ... | TILTON GLENN F | Chairman,President ... | Payment of Exercise | F | 0.74 | 9,862 | 7,298 | 90,138 | 100 K to 90.1 K (-9.86 %) |
| Sep 04 2003 | UAL | United Continental ... | TILTON GLENN F | Chairman,President ... | Payment of Exercise | F | 0.74 | 9,862 | 7,298 | 90,138 | 100 K to 90.1 K (-9.86 %) |
| Sep 04 2003 | UAL | United Continental ... | TILTON GLENN F | Chairman,President ... | Payment of Exercise | F | 0.74 | 9,862 | 7,298 | 90,138 | 100 K to 90.1 K (-9.86 %) |
Page: 1